Combination chemotherapy for disseminate
โ
John J. Costanzi; V. K. Vaitkevicius; Joseph M. Quagliana; Barth Hoogstraten; Ch
๐
Article
๐
1975
๐
John Wiley and Sons
๐
English
โ 389 KB
๐ 2 views
BCNU, hydroxyurea, a n d imidazole carboxamide (DTIC) were administered to 89 patients with disseminated malignant melanoma. A response rate of 27% was observed. The addition of vincristine in another 89 patients did not significantly improve the response rate (30%). This includes patients who died